Cost and quality of life analysis of HIV self-testing and facility-based HIV testing and counselling in Blantyre, Malawi

Table 2 Annual direct health provider costs of HIV testing and counselling

	Ndirande clinic			Chilomoni clinic			QECH HTC clinic^a			HIVST service
Cost category	US Dollars (2014)	INT Dollars (2014)	% of Total^b	US Dollars (2014)	INT Dollars (2014)	% of Total^b	US Dollars (2014)	INT Dollars (2014)	% of Total^b	US Dollars (2014)	INT Dollars (2014)	% of Total^b
Staff salaries	6,738	24,545	17 . 9 %	6,433	15,019	11 . 1 %	8,710	24,195	12 . 5 %	23,066	79,431	30 . 3 %
Staff training	353	982	0 . 7 %	530	1,472	1 . 1 %	353	982	0 . 5 %	12,268	34,077	13 . 0 %
Monitoring and evaluation	2,098	5,828	4 . 3 %	5,785	16,069	11 . 9 %	2,920	8,111	4 . 2 %	15,833	54,521	20 . 8 %
Consumables and equipment	38,453	96,475	70 . 5 %	40,910	94,070	69 . 6 %	60,324	126,995	65 . 5 %	82,133	94,051	35 . 9 %
Capital/Overheads	3,257	9,047	6 . 6 %	3,102	8,618	6 . 4 %	12,129	33,691	17 . 4 %	0	0	0
Total annual health provider cost	50,899	136,876		56,760	135,248		84,436	193,973		133,300	262,080
Individuals tested	6759			5372			9488			15190
Direct cost per individual tested	7 . 53	20 . 25		10 . 57	25 . 18		8 . 90	20 . 44		8 . 78	17 . 25
HIV positive identified	756			743			2984			1367^c
Direct cost per HIV positive identified	67 . 33	181 . 05		76 . 39	182 . 03		28 . 30	65 . 00		97 . 50	191 . 70
Direct cost per HIV positive individuals assessed for ART eligibility	83 . 48	224 . 51		92 . 38	220 . 13		37 . 73	86 . 67		165.14	324.67
										(173.05)^d	(340.23)^d
										(233.90)^e	(459.86)^e
Direct cost per HIV positive initiated onto ART	109 . 85	295 . 40		132 . 42	315 . 52		85 . 75	196 . 98		319.67	628.50

^aOutpatient HIV Testing and counselling clinic at Queen Elizabeth Central Hospital
^bPercentages based on costs estimated in International Dollars
^cEstimated from HIV prevalence reported in main trial
^dHigh linkage rate (56.3 %) from main trial used to estimate cost per individual assessed for ART eligibility [15]
^eLow linkage rate (41.7 %) from main trial used to estimate cost per individual assessed for ART eligibility [15]

ISSN: 1741-7015